Rhabdomyolysis during therapy with daptomycin
- PMID: 16705566
- DOI: 10.1086/504379
Rhabdomyolysis during therapy with daptomycin
Abstract
The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
